← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › IMMUNE SERA AND IMMUNOGLOBULINS › IMMUNOGLOBULINS › Specific immunoglobulins
measles immunoglobulin
J06BB14
Forms & Strengths
- injection: 100-400 mg
- lyophilized powder for injection
Adult Dosing
- intramuscular injection: 0.55 mL/kg (max 15 mL)
- dosage may vary based on clinical condition
Pediatric Dosing
- intramuscular injection: 0.55 mL/kg (max 15 mL)
- dosage for children under 1 year: 0.1-0.2 mL/kg
Indications
- postexposure prophylaxis of measles
- modification of measles in immunocompromised patients
- immunoprophylaxis in immunodeficient patients
Mechanism of Action
- neutralizes measles virus
- binds to measles virus, preventing replication
- provides passive immunity
Contraindications
- hypersensitivity to immunoglobulins
- selective IgA deficiency
- allergy to human proteins
Adverse Reactions
- injection site pain
- headache
- fatigue
- nausea
- anaphylaxis (rare)
Drug Interactions
- live virus vaccines: may interfere with vaccine efficacy
- other immunoglobulins: may increase risk of adverse reactions
Curated Content: Needs Vetting Before Put to Clinical Use